NHS enters major deal to expand hospital capacity, including 8,000 beds
The independent sector will also reallocate practically its entire national hospital capacity to the NHS.
Read More
Author: Anna Smith
ViiV sees first global approval of Cabenuva in Canada
Canada has also approved Vocabria to be used for short time periods in conjunction with the drug.
Read More
COVID-19: CMA, NIHR, AbbVie updates
The current recorded case count for COVID-19 (coronavirus) in the UK has hit 3,269, with 144 deaths and 65 recoveries.
Read More
£27 million pledged to fight “world’s biggest killers”
The company will be able to accelerate the development of an innovative drug and technology pipeline, born from The George Institute’s research program.
Read More
FDA OKs Gilead’s paediatric hep C drug
Epclusa is the first pan-genotypic, protease inhibitor-free regimen approved in the United States for adults and children.
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
